🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I, first-in-human dose-escalation study was conducted to determi...
Status
Completed
Location
Guangdong General Hospital
Start Date
2016-04
Trial ID
NCT02896231
Treatments Being Tested
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC...
Status
Recruiting
Location
Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute
Start Date
2017-09-27
Trial ID
NCT03175224
Treatments Being Tested
Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 as the First-lin...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-08-07
Trial ID
NCT06574347
Treatments Being Tested
This is a Phase 1, open-label, multi-center, randomized, 2-period, adaptive...
Status
Unknown
Location
New Zealand Clinical Research
Start Date
2022-05-20
Trial ID
NCT05367388
This study aim to evaluate the efficacy and safety of Bozitinib combined wi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-20
Trial ID
NCT07153770
Treatments Being Tested
This is a Prospective, open label, single arm study to evaluate the efficac...
Status
Active Not Recruiting
Location
Cancer insititue and Hospital of CHINESE ACADEMY OF MEDICAL SCIENCE
Start Date
2024-10-14
Trial ID
NCT06827145
Treatments Being Tested
Study Design and Investigational Plan: This is an open-label Phase 1/2 stu...
Status
Terminated
Location
Border Medical Oncology Research Unit
Start Date
2018-09-05
Trial ID
NCT03655613
Efficacy and Safety of Vebreltinib in Combination With PLB1004 Versus Plati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06970782
Treatments Being Tested
This is a descriptive observational study in which data are collected in an...
Status
Recruiting
Location
Hunan Province Tumor Hospital
Start Date
2020-01-01
Trial ID
NCT06183762
Treatments Being Tested
This phase I, open-label, dose-escalation study was conducted to determine ...
Status
Completed
Location
Beijing Shijitan Hospital,CMU
Start Date
2016-09
Trial ID
NCT02978261
Treatments Being Tested